The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 33.00
Bid: 32.50
Ask: 33.50
Change: 0.00 (0.00%)
Spread: 1.00 (3.077%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 33.00
DUKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading and Operational Update

28 Mar 2024 07:00

RNS Number : 6028I
Duke Capital Limited
28 March 2024
 

28 March 2024

Duke Capital Limited

 

("Duke Capital", "Duke" or the "Company")

 

Trading and Operational Update

 

Duke Capital Limited (AIM: DUKE), a leading provider of hybrid capital solutions for SME business owners in Europe and North America, is pleased to provide the following trading update for its third quarter of the financial year ending 31 December 2023 ("Q3 FY24"), and to provide guidance on trading for its fourth quarter ending 31 March 2024 ("Q4 FY24").

 

Q3 FY24 Trading Update

 

· Recurring revenue for Q3 FY24 reached a record of £6.3 million, an increase of 12% over Q3 FY23. Total cash revenue was also £6.3 million.

 

· Q3 FY24 represents over three continuous years of increasing quarterly recurring cash revenue, with total growth of 350% from the £1.8 million in the quarter ending September 2020 to £6.3 million for the last quarter ending December 2023.

 

Q4 FY24 Trading Guidance

 

· Duke forecasts total cash revenue of £10.2 million in Q4 FY24, a record quarter marking the first time Duke has generated more than £10 million in a single quarter. This represents a material 30% increase over the Company's previous record of £7.8 million which was achieved in Q1 FY24.

 

· During the quarter, Duke delivered two material and profitable buyouts, that have returned over £19 million which the Company will use for near-term deployments in new and existing partners.

 

· Duke expects to achieve recurring cash revenue of £5.8 million in Q4 FY24, a small decrease versus the previous quarter. While the recent buyouts have resulted in increased total cash revenue, until this capital is redeployed, there is a temporary impact of reduced recurring cash revenue. 

 

Overview of quarterly revenue growth:

 

 

Recurring Cash Revenue*

Total Cash Revenue**

Q3 FY23

£5.6 million

£5.6 million

Q4 FY23

£5.7 million

£5.8 million

Q1 FY24

£6.0 million

£7.8 million

Q2 FY24

£6.2 million

£6.2 million

Q3 FY24

£6.3 million

£6.3 million

 

* Recurring cash revenue excludes exit premium receipts and cash gains from equity sales

** Total cash revenue is monthly cash distributions from Duke's partners plus cash gains received from the sales of equity assets and exit premiums

 

 

Operational Update

 

· In February, Duke completed a £2.9 million secondary share purchase from existing shareholders in United Glass Group, increasing its equity stake from 30% to 74%, in line with Duke Capital's vision to deepen its engagement with its high performing partners.

· In March, Duke delivered two highly profitable exits from Fabrikat and Fairmed Healthcare, which has significantly bolstered Duke's liquidity which currently stands at approximately £44 million.

· The Company has a strong pipeline of both new and follow-on opportunities for capital partners to deploy additional liquidity.

· During the quarter, Duke also completed its change of name and renewed messaging. The review has focused on ensuring that Duke's unique offering is communicated to business owners and stakeholders in a way which provides greater clarity and improves comparison when evaluating a broad array of financing options.

 

Neil Johnson, CEO of Duke Capital, said:

 

"We are delighted to show a record quarter of total cash revenue following the successful exits of two of our investments. Fabrikat particularly highlighted the value of Duke's capital, having financed an MBO by three executives in 2021, facilitating an exit three years later at a 36% IRR. We look forward to redeploying the capital from these exits into our pipeline of immediate and longer-term opportunities, driving a return in the short-term to delivering record quarterly recurring cash revenues.

 

Following the completion of our name change and corporate re-branding, Duke Capital is looking forward to FY25 with renewed optimism. With a strengthened liquidity position and strong pipeline, we are well-equipped to navigate the challenges and opportunities that lie ahead, while remaining cautious of the economic backdrop."

 

 

***ENDS***

 

For further information, please visit https://dukecapital.com/ or contact:

 

Duke Capital Limited

Neil Johnson / Charles Cannon Brookes / Hugo Evans

 

+44 (0) 1481 231 816

Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker)

Stephen Keys / Callum Davidson / Michael Johnson 

+44 (0) 207 220 0500

 

Canaccord Genuity Limited

(Joint Broker)

 

Adam James / Harry Rees

+44 (0) 207 523 8000

SEC Newgate (Financial Communications)

Elisabeth Cowell / Alice Cho / Matthew Elliott

+ +44 (0) 20 3757 6882 dukecapital@secnewgate.co.uk

 

 

About Duke Capital

 

Duke is a leading provider of hybrid capital solutions for SME business owners in Europe and North America, combining the best features of both equity and debt.

 

Since 2017, Duke has provided unique long-term financing which eliminates re-financing risk and necessity for a short-term exit by providing a unique 'corporate mortgage' while also aligning its returns to grow with the success of the business.

 

Duke is focused on generating attractive risk-adjusted returns for shareholders and has a track record of achieving this across market cycles. It's three investment pillars are capital preservation, attractive dividend yield, and to provide upside upon exits.

 

Duke is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTQKOBPKBKBANB
Date   Source Headline
19th Mar 20197:00 amRNSDividend Declaration
14th Mar 20197:00 amRNSChange of Adviser
19th Feb 20197:00 amRNSNew Royalty Finance Agreement
5th Feb 20191:50 pmRNSHolding(s) in Company
4th Feb 20197:00 amRNSAcquisition of UK royalty finance provider
17th Dec 20187:00 amRNSFollow-on contribution to royalty partner
5th Dec 20187:00 amRNSIssue of Shares and Total Voting Rights
4th Dec 20187:00 amRNSInterim results and dividend declaration
27th Nov 201811:31 amRNSDuke Royalty to Present at Mello London
31st Oct 20187:00 amRNSLTIP Awards and other Issuances
30th Oct 20187:00 amRNSOperational and Corporate Update
28th Sep 20187:00 amRNSFurther Contribution to Royalty Partner
24th Sep 20187:00 amRNSFinal Results and Notice of AGM
20th Sep 20187:00 amRNSDividend Declaration and Notice of Results
30th Aug 20187:00 amRNSNew Royalty Agreement
6th Aug 20184:50 pmRNSNotification of major holdings
6th Aug 20184:45 pmRNSNotification of major holdings
6th Aug 20183:18 pmRNSHolding(s) in Company
6th Aug 20181:18 pmRNSNotification of Major Holdings
2nd Aug 201812:20 pmRNSResult of EGM and Issue of Equity
16th Jul 20187:00 amRNSFundraising to raise £44m and EGM announcement
13th Jul 20184:56 pmRNSFundraising to raise £44 million and notice of EGM
19th Jun 20187:00 amRNSInterim Dividend Increase
14th Jun 20187:01 amRNSRoyalty finance agreement LOI and secured loan
14th Jun 20187:00 amRNSUpdate on Exclusive Collaboration
8th May 20187:00 amRNSOperational Update on Royalty Partners
26th Apr 20187:00 amRNSFurther Contribution to Royalty Partner
24th Apr 20187:00 amRNSNew Royalty Agreement
16th Apr 20181:34 pmRNSDuke Royalty at Berenberg UK Corporate Conference
13th Mar 20187:00 amRNSInterim Dividend Increase & Dividend Declaration
8th Mar 20187:00 amRNSDirector/PDMR Shareholdings
6th Mar 20187:00 amRNSLong Term Incentive Plan Awards
5th Mar 20187:00 amRNSNew Royalty Finance Agreement
27th Feb 20187:00 amRNSDuke Royalty Appoints Redleaf Communications
2nd Jan 20184:51 pmRNSHolding(s) in Company
22nd Dec 201712:09 pmRNSHolding(s) in Company
21st Dec 201710:36 amRNSResult of EGM and Issue of Equity
19th Dec 201712:49 pmRNSInterim Dividend
5th Dec 20173:18 pmRNSResult of the Fundraising and Notice of EGM
4th Dec 20174:48 pmRNSProposed Fundraising to raise at least £20 million
13th Nov 20179:39 amRNSFurther Contribution to Royalty Partner
8th Nov 20177:05 amRNSUnaudited Interim Results
8th Nov 20177:00 amRNSStrategic Advisory Agreement
9th Oct 201711:01 amRNSDirector/PDMR Shareholding
6th Oct 20177:00 amRNSNew Royalty Finance Agreement
28th Sep 20172:47 pmRNSBoard changes and investment team addition
27th Sep 201711:46 amRNSResult of AGM
21st Sep 20173:14 pmRNSHolding(s) in Company
21st Sep 20177:00 amRNSChange of Adviser and Interim Dividend
22nd Jun 20173:19 pmRNSFinal Results and Maiden Dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.